Cellular based immunotherapy for primary liver cancer

Primary liver cancer (PLC) is a common malignancy with high morbidity and mortality. Poor prognosis and easy recurrence on PLC patients calls for optimizations of the current conventional treatments and the exploration of novel therapeutic strategies. For most malignancies, including PLC, immune cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yuanyuan, Li, Yan, Feng, Jiao, Li, Jingjing, Ji, Jie, Wu, Liwei, Yu, Qiang, Dai, Weiqi, Wu, Jianye, Zhou, Yingqun, Guo, Chuanyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351445/
https://www.ncbi.nlm.nih.gov/pubmed/34372912
http://dx.doi.org/10.1186/s13046-021-02030-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351445/
https://www.ncbi.nlm.nih.gov/pubmed/34372912
http://dx.doi.org/10.1186/s13046-021-02030-5

Ejemplares similares